About i-sep
i-sep is a company based in Nantes (France) founded in 2015 by Sylvain Picot. i-sep has raised $3.61 million across 2 funding rounds from investors including GO CAPITAL. i-sep offers products and services including sameâ„¢ system and IOCS Technology. i-sep operates in a competitive market with competitors including Haemonetics, VISIE, Sisu Global Health, Scinovia and Haermonics, among others.
- Total Equity Funding$3.61M (USD)
in 2 rounds
- Latest Funding Round$2.73M (USD), Series A
Sep 2019
- Investors
Products & Services of i-sep
i-sep offers a comprehensive portfolio of products and services, including same™ system and IOCS Technology.
Technology for recovering red blood cells and platelets in surgeries.
System that enables intraoperative cell salvage for patient safety.
Funding Insights of i-sep
i-sep has successfully raised a total of $3.61M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.73 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.61M
- Total Rounds 2
- Last Round Series A — $2.73M
- First Round $880,104
(Nov 2015)
- Investors Count 1
All 2 funding rounds of i-sep with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2019 | $2.73M | Series A | – | GO CAPITAL | – |
| Nov 2015 | $880,104 | Seed | – | GO CAPITAL | – |
1 investors in total: 1 institutional.
Investors in i-sep
i-sep has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include GO CAPITAL.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed toward multiple sectors. | 2003 | gocapital.fr | Rennes, France |
Investor details for i-sep
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of i-sep
4 people are tracked at i-sep (2 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Sylvain Picot | Co-Founder & CEO | Leadership |
Georges Tabary | VP Business Development, Board Member | Leadership |
Amandine COMBRES | Key Account Manager | Team |
Philippe Francy | Senior Business Advisor | Team |
Complete people profiles for i-sep
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of i-sep
3 dated milestones of i-sep across 4 years, from founding to its latest funding, stage changes and deals.
- Founded i-sep is founded.
- Funding First funding round of $880K.
- Funding Latest funding round, Series A, of $2.7M.
Competitors of i-sep
i-sep operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Haemonetics, VISIE, Sisu Global Health, Scinovia and Haermonics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| haemonetics.com | 1971 | Braintree, United States | – | 3,034 | Hematology products and solutions are provided for medical applications. | |
| visievision.com | 2017 | Austin, United States | $12.71M | – | Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery | |
| sisuglobal.health | 2014 | Baltimore, United States | – | – | Intraoperative autotransfusion devices are developed and provided. | |
| scinovia.com | 2014 | Durham, United States | $6.91M | 10 | Augmented-reality surgical cameras for blood flow visualization are developed. | |
| haermonics.com | 2015 | Amsterdam, Netherlands | $4.41M | – | Postoperative pericardial drainage and flushing system is developed. | |
| procellsi.com | 2015 | Canton, United States | – | – | Develops medical devices for intraoperative blood recovery and conservation. | |
| perfusio.com | 2014 | Greenville, United States | $7.79M | – | Blood-flow imaging devices for surgical procedures are developed. | |
| swabtech.co.uk | 2012 | Manchester, United Kingdom | $938,127 | – | Offers a device for intra-operative blood recovery from swabs. |
Detailed competitors of i-sep
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of i-sep
The website of i-sep (i-sep.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▲ 292.9% vs previous month
Similar companies to i-sep
10 companies that operate in the same segment as i-sep (Medical Equipment & Supplies), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Software and integrated solutions for surgical and radiotherapy applications | 1989 | Munchen, Bayern, Germany | USD 12.68 M | USD 1.18 M | 18 | |
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Collaborative surgical robotic systems are provided for hospital procedures. | 2014 | Cambridge, Cambridgeshire, United Kingdom | USD 1.32 B | – | – | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.17 M | – | 242 | |
Augmented reality systems for guiding surgical procedures are developed. | 2014 | Yokneam Illit, North District, Israel | USD 142.6 M | – | – | |
Manufacturer of imaging and surgical products | 1919 | Tokyo, Tokyo, Japan | – | USD 6.49 B | 35,933 | |
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | – | USD 3.07 B | 10,600 | |
Rapid infusion systems are provided for critically ill patients. | 2012 | Durham, North Carolina, United States | USD 77.98 M | – | – | |
Mobile robots are manufactured for industries including healthcare and agriculture. | 2013 | Odense, Denmark | USD 81.44 M | – | 303 | |
Visualization systems for surgical procedures are developed using machine learning. | 2016 | Seattle, Washington, United States | USD 74.25 M | – | 52 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about i-sep
i-sep was founded in 2015.
i-sep is headquartered in Nantes, France. It is registered at Nantes, Pays De La Loire, France.
Sylvain Picot is the current CEO of i-sep. They have also founded this company.
i-sep is a funded company, having raised a total of $3.61M across 2 funding rounds to date. The company's 1st funding round was a Seed of $880.1K, raised on Nov 2015.
i-Sep develops advanced cell salvage solutions. Intraoperative blood salvage, also known as autologous blood transfusion or cell salvage, is a medical procedure involving recovering blood lost during surgery and re-infusing it into the patient. It is a form of autotransfusion. These are used frequently in cardiothoracic and vascular surgery, in which blood usage has traditionally been high. With a greater effort to avoid adverse events due totransfusion there has also been an emphasis on blood conservation.
i-sep's top competitors include Haemonetics, VISIE and Sisu Global Health.
i-sep offers sameâ„¢ system and IOCS Technology.
i-sep has 1 investor. Key investors include GO CAPITAL.